GPT and metabolic dysfunction-associated steatotic liver disease: Clinical studies have also demonstrated that males with MASLD often exhibit more pronounced markers of liver injury and metabolic disturbances, particularly elevated alanine aminotransferase (ALT) and serum uric acid (SUA) levels [17,19].